Nicole Vitullo, Director at Esperion Therapeutics, Inc. (ESPR), sold 370,969 shares at $53.85 ($502K) on 2017-12-06, disclosed to the SEC on 2017-12-08.
Open-market sale of $502k ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 329,083 | $0 | 0.0% |
| 2 | $53.85 | 9,326 | $502K | 100.0% |
| 3 | $0.00 | 32,560 | $0 | 0.0% |
| Total | $1.35 avg | 370,969 | $502K | 100% |
| Filing → |
| ESPR | SELL | 2018-01-26 | $1.7M | — | Filing → |
| CLCD | SELL | 2016-05-02 | $2.1M | — | Filing → |
| EVOK | SELL | 2016-04-27 | $415 | — | Filing → |